ST-elevation Myocardial Infarction (STEMI): Clinical Trials

1 trial for ST-elevation Myocardial Infarction (STEMI), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow ST-elevation Myocardial Infarction (STEMI): new trials by email Literature Review of ST-elevation Myocardial Infarction (STEMI) trials Research Report on ST-elevation Myocardial Infarction (STEMI)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI
zalunfiban, Placebo - ST-elevation Myocardial Infarction (STEMI)
Phase 3Active not recruitingCeleCor Therapeutics24632021-04-242025-10-23

Narrower conditions

ST Elevation Myocardial Infarction (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Myocardial Infarction (1)  ·  Myocardial Ischemia (1)  ·  Necrosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Sponsors

CeleCor Therapeutics (1)

Countries

Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Hungary (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Romania (1)  ·  United States (1)

Results publications

PMID 36592878, PMID 41211981, PMID 41728285, PMID 42303064, PMID 42727626